The global Cell Therapy Market is forecast to reach USD 8.75 Billion by 2027, according to a new report by Reports and Data. The market for cell therapy is observing a high demand due to the rise in the number of clinical trials across the world. These therapies are used in regenerative medicine, especially for degenerative and immunogenic pathologies. However, the applications of cell therapy in oncology will experience higher growth, owing to a large number of pipeline projects for the treatment of tumors or cancer.
Leading Players Profiled in the Report Include:
JCR Pharmaceuticals Co. Ltd., Fibrocell Science, Inc., Kolon TissueGene, Inc., Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., MEDIPOST, Stemedica Cell Technologies, Inc., Cells for Cells, Vericel Corporation, and ANTEROGEN Co., Ltd., among others.
The inception of effective guidelines for cell therapy manufacturing, the development of advanced genomic analysis techniques, a vast number of research by cancer societies, and proven effectiveness of transplants are some of the primary growth stimulants for the market. Certain pharmacological and manufacturing issues and regulatory hurdles are restricting the growth of the market.
The Japanese government has recognized cell therapy and regenerative medicine as a major donor to the country’s economic growth. This has influenced the attention of global market players towards the Asian market, thereby fostering marketing operations in the region.
Many deals and new companies are coming up to boost the research in cell therapy. UK Biotech startup Bit Bio received a €36.9 million Series A funding, in June 2020, to boost the manufacturing efficiency of human cells for application in cell therapy and drug discovery.
Get a Sample Report PDF with Detail TOC & List of Figures @ https://www.reportsanddata.com/sample-enquiry-form/3269
The COVID-19 impact:
The market for cell therapy will witness a surge in demand as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A remarkable number of biotech firms are in the midst of the race to scrutinize the virus’s genome and are trying to develop a viable vaccine. These companies are investigating the virus at an unparalleled rate, and considerable funds are being invested into the research. The companies are in trial, and the private and public sectors are working continuously for the development of the vaccine.
Further key findings from the report suggest
Allogeneic Stem Cell Therapy dominated the therapy type segment. The segment is advantageous as they produce their own immune stem cells, which can kill cancer cells that remain even after high-dose cytotoxic drugs treatment. The patients those have a high risk of relapse after successful treatment of chemotherapy are recommended allogeneic transplants. The rising cases of cancer relapse have fueled the demand for the segment.
Stem cell banking is gaining popularity from the initiatives taken by the government. The number of stem cell banks are increasing in developing nations, which is further propelling market growth. Also, increasing awareness regarding the storage of stem cells has had a positive effect on the market. The market is still at a nascent stage, but it holds potential in both therapeutic and diagnosis fields.
Hospitals and clinics are forecasted to grow at a significant CAGR of 5.8% during the forecast period. The lucrative growth in the segment is due to the increase in the number of pipeline projects over the past few years. As per the Cancer Research Institute (CRI), the number of projects rose from 753 in 2018 to 1,011 in 2019.
Cell therapy has been observed to induce profound healing activity in animals with different forms of autoimmune disorders. Besides healing damaged tissues, it has the unique ability to modulate the immune system while preserving its ability to fight off disease.
North America is anticipated to account for a significant share of the global cell therapy market. The United States will be the major contributor and is expected to witness high growth owing to the huge amount of funding by the government and private firms for clinical trials.
Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3269
For the purpose of this report, Reports and Data have segmented the global Cell Therapy Market on the basis of therapy type, therapeutic area, cell type, end-user, and region:
Therapy Type Outlook (Revenue, USD Billion; 2017-2027)
- Allogenic Stem Cell Therapy
- Autologous Stem Cell Therapy
Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
- Autoimmune Disorders
- Musculoskeletal Disorders
Cell Type Outlook (Revenue, USD Billion; 2017-2027)
- Stem Cells
- Non-Stem Cells
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Academic & Research Institutes
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Saudi Arabia
- Rest of MEA
Browse Complete Report “Cell Therapy Market” @ https://www.reportsanddata.com/report-detail/cell-therapy-market
Table of contents
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Cell Therapy Market Segmentation & Impact Analysis
4.1. Cell Therapy Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
126.96.36.199. Increase in adoption of regenerative medicine
188.8.131.52. Introduction of new technologies
4.2.3. Market restraints analysis
184.108.40.206. Ethical reasons related to stem cell research
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States